cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Organogenesis Holdings Inc
3 own
3 watching
Current Price
$2.56
$0.08
(3.23%)
logo-orgo
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
335.14M
52-Week High
52-Week High
9.27
52-Week Low
52-Week Low
2.23
Average Volume
Average Volume
0.65M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
21.5351
iconMarket Capitalization335.14M
icon52-Week High9.27
icon52-Week Low2.23
iconAverage Volume0.65M
iconDividend Yield--
iconP/E Ratio21.5351
What does the Organogenesis Holdings Inc do?
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company s advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediate layer intact; PuraPly , a antimicrobial barrier that enables conformability and fluid drainage; and Novachor, an amniotic membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved. Its surgical and sports medicine products comprise NuCel, a dehydrated placental tissue surgically applied to the target tissue to support native healing; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.
Read More
How much money does Organogenesis Holdings Inc make?
News & Events about Organogenesis Holdings Inc.
Globe Newswire
2 months ago
NEW YORK, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Sleep Number Corporation (NASDAQ: SNBR) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Sleep Number alleging that Defendants made false and misleading statements and failed to disclose that: (i) Sleep ...
Zolmax
2 months ago
Organogenesis Holdings Inc. (NASDAQ:ORGO Get Rating) Equities researchers at Oppenheimer dropped their FY2023 EPS estimates for shares of Organogenesis in a note issued to investors on Thursday, November 10th. Oppenheimer analyst S. Lichtman now expects that the company will post earnings per share ...
Globe Newswire
4 months ago
CANTON, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today ...
PR Newswire
6 months ago
Thinking about buying stock in Selecta Biosciences, Adial Pharmaceuticals, Exela Technologies, Theravance Biopharma, or Organogenesis? Thinking about buying stock in Selecta Biosciences, Adial Pharmaceuticals, Exela Technologies, Theravance Biopharma, or Organogenesis? PR Newswire NEW YORK, July...
Zolmax
7 months ago
Organogenesis Holdings Inc. (NASDAQ:ORGO Get Rating) major shareholder Albert Erani sold 100,000 shares of the stock in a transaction that occurred on Monday, June 6th. The shares were sold at an average price of $5.41, for a total value of $541,000.00. Following the transaction, the insider now ...
Frequently Asked Questions
Frequently Asked Questions
What is Organogenesis Holdings Inc share price today?
plus_minus_icon
Can Indians buy Organogenesis Holdings Inc shares?
plus_minus_icon
How can I buy Organogenesis Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Organogenesis Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Organogenesis Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Organogenesis Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Organogenesis Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Organogenesis Holdings Inc?
plus_minus_icon
What percentage is Organogenesis Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Organogenesis Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.56
$0.08
(3.23%)
logo-orgo
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00